MoneyWorks4Me

Lincoln Pharmaceuticals informs about statement of investor complaints

10 Jan 2018 Evaluate

Lincoln Pharmaceuticals has informed about the Copy of Investors Complaints for the Quarter Ended on December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..